Asahi Group Holdings would begin making minority investments in US start-ups from January 2023 through its Asahi Group Beverages & Innovation Fund which will open up new markets for low-alcohol and non-alcohol beverages.
The fund will support US start-ups that have "attractive brands" with significant future growth potential in the non-alcoholic beer-taste beverages, adult soft drink beverages, and low-alcohol categories.
It would also support start-ups with technology that leads to new sales and manufacturing methods, according to Atsushi Katsuki, president and CEO of Asahi Group Holdings.
Asahi will use its business platform to encourage sales growth for the goods and services offered by such enterprises both domestically and internationally.
By the end of 2025, the total investment is anticipated to be around $70 million. Employees recruited from the regional headquarters of Asahi Group will serve as the investment managers for Asahi Group Beverages & Innovation.


SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
Why a ‘rip-off’ degree might be worth the money after all – research study
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts
Rising U.S.-Iran Conflict Fuels Oil Market Volatility and Ceasefire Uncertainty
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
John Ternus Signals Apple’s Future with Product-First AI Strategy
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential
Home ownership is slipping out of reach. It’s time to rethink our fear of ‘forever renting’
Can your cat recognise you by scent? New study shows it’s likely
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Japan Exports Surge for Seventh Month as AI Demand Offsets Middle East Trade Disruptions
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Infosys Shares Drop Amid Earnings Quality Concerns 



